Meeting Coverage

After a colonoscopy, patients with inactive IBD were more likely to present to the ED, be hospitalized, and be prescribed steroids within 30 days.

Patients with psoriasis in special areas report greater HRQOL impairment and symptom severity compared with those without special area involvement.

Patients with psoriasis are known to be at a higher risk of various cardiovascular risk factors.

The following is a summary of “Baseline Data and Measurement Instruments Reported in Observational...

Several studies were presented at the 2024 Crohn’s & Colitis Congress, covering the impacts on IBD of malnutrition, dietary supplements, and various diets.

A recent study and meta-analysis revealed that inflammatory bowel disease (IBD) is associated with...

A study found that preoperative exclusive enteral nutrition (EEN) in patients with Crohn’s...

Investigators concluded that AI-powered “vascular healing” analysis in UC pinpointed patients...

Patient-reported outcomes on HRQOL in psoriasis are limited and require additional validation to properly assess individuals with the condition.

Research from ASH 2023 showed standard treatment options lack efficacy for patients who are positive for the TP53 mutation with AML.

A retrospective study on advanced therapy for Inflammatory Bowel Disease (IBD) found minimal new...

A recent study found that long-term use of recombinant zoster vaccine (RZV) was associated with a...

At Maui Derm Hawaii, Joel Gelfand, MD, MSCE, presented as part of “Challenging Cases in Psoriasis.” He published 2 related papers recently, which we summarize.

Bruce Strober, MD, PhD, published a paper recently in JAMA Dermatol focusing on disease burden measurements of meaning to patients with psoriasis.